The UK government has announced £133 million funding for innovative health projects which will help to treat some of the most chronic and debilitating illnesses.
According to the Government, the funding will help to future-proof the NHS and realise the visions articulated in the NHS Long Term Plan. This will be channelled through UK Research and Innovation (UKRI).
Secretary of State for Health and Social Care Matt Hancock commented:
“We’ve got to bring NHS technology into the 21st century. I’ve seen for myself how better technology and diagnosis can save clinicians’ time so they can concentrate on care. The NHS is now spearheading world-leading technologies that can transform and save lives through new treatments, diagnosis techniques and care. I’m determined that the benefits of these advances will improve the lives of thousands of patients whose conditions have long been considered life-limiting.”
The £133 million funding will be spent on:
- £69.5 million to fund the Nucleic Acid Therapy Accelerator, the Advanced Pain Discovery Platform, the UK Centre of Evidence Implementation in Adult Social Care and to tackle multi-morbidity
- £50 million for NHS Diagnostic Services and to support Centres of Excellence to further developments in artificial intelligence and digital pathology
- £14 million for bioscience projects and technologies, which will help to develop vaccines and treat osteoarthritis
Minister for Innovation in the Department of Health and Social Care Nicola Blackwood said:
“The UK is a global powerhouse in health research and innovation. The investments announced today will cement this, and help to further deliver on the NHS’s international leadership on applying artificial intelligence to complex health problems. Today’s announcement is good for patients, good for staff and good for researchers.”
Read more from the announcement here.